Legal Representation
Attorney
Robert S. Broder
USPTO Deadlines 1 active 1 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
OPPOSITION
Notice of Publication |
NPUB | Oct 05, 2023 | 641 days overdue | Medium | Until Nov 05, 2023 |
Application History
30 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 18, 2024 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Feb 22, 2024 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Feb 22, 2024 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Feb 21, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Nov 21, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Nov 21, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Oct 16, 2023 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Sep 27, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Sep 27, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Sep 5, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 5, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sep 4, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Aug 16, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Aug 16, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Aug 16, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Jul 28, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 27, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jul 26, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 26, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| May 27, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| May 14, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Mar 15, 2023 | RFNT | P | REFUSAL PROCESSED BY IB |
| Feb 22, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Feb 22, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Dec 27, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Dec 26, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Dec 13, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 26, 2022 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Apr 22, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 21, 2022 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Probiotic bacterial formulations for medical use; probiotic supplements; pharmaceutical and medicinal preparations for use in the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical and medicinal preparations for use in the treatment of gastro-intestinal, immunity and uro-genital disorders, hyperlipidemia, sunburn, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, damaged skin and tissue, eye diseases and conditions, skin disorders, diabetes, erectile dysfunction, bone diseases, immune system related diseases and disorders, allergies, hypertension, epidermis, respiratory diseases, cardiovascular disorders, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, respiratory diseases, asthma, allergic rhinitis, viral infections, gastro-intestinal diseases, halitosis, viral diseases, autoimmune diseases; pharmaceutical preparations for skin care; pharmaceutical preparations for use in urology; pharmaceutical preparations for the prevention of gastro-intestinal and urogenital infections, seasonal illness, common colds, cardiovascular disease, gastro-intestinal or local dysbiosis, allergies; pharmaceutical preparations for wounds; pharmaceutical preparations for animal skincare; pharmaceutical preparations acting on the central nervous system; dermatological pharmaceutical products; pharmaceutical skin lotions; pharmaceutical products for skin care for animals; anti-diabetic pharmaceuticals; ferments for pharmaceutical purposes; pharmaceutical agents affecting metabolism; ferments for pharmaceutical purposes, namely, for gastro-intestinal, immunity and uro-genital disorders; digestives for pharmaceutical purposes; pharmaceutical preparation for skin care; pharmaceuticals, namely, lipid lowering agents; milk ferments for pharmaceutical purposes
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005